GRI, Giorgia
 Distribuzione geografica
Continente #
NA - Nord America 3.265
EU - Europa 567
AS - Asia 192
SA - Sud America 1
Totale 4.025
Nazione #
US - Stati Uniti d'America 3.260
UA - Ucraina 236
CN - Cina 106
IT - Italia 87
DE - Germania 84
FI - Finlandia 73
IE - Irlanda 37
SG - Singapore 31
IR - Iran 25
SE - Svezia 18
BE - Belgio 14
IN - India 13
TR - Turchia 12
GB - Regno Unito 10
CA - Canada 5
VN - Vietnam 4
PL - Polonia 2
AT - Austria 1
BG - Bulgaria 1
BR - Brasile 1
CZ - Repubblica Ceca 1
GR - Grecia 1
KR - Corea 1
NO - Norvegia 1
RO - Romania 1
Totale 4.025
Città #
Fairfield 558
Woodbridge 494
Houston 275
Ashburn 245
Seattle 227
Ann Arbor 203
Chandler 181
Wilmington 162
Jacksonville 154
Cambridge 149
Dearborn 71
Beijing 64
Udine 54
New York 46
Princeton 39
Dublin 37
San Diego 25
Singapore 22
Brussels 14
Leawood 13
Boardman 12
Des Moines 12
Izmir 10
Ogden 10
Zanjan 9
Hefei 7
Nanjing 7
Ardabil 6
Augusta 6
Cedar Knolls 6
Norwalk 6
Kunming 5
Dong Ket 4
Grafing 4
Guangzhou 4
Kish 4
Monmouth Junction 4
Trieste 4
Shenyang 3
Toronto 3
Andover 2
Ankara 2
Chengdu 2
Colleferro 2
Dulles 2
Fuzhou 2
Indiana 2
Jinan 2
London 2
Monreale 2
Mumbai 2
Phoenix 2
Redmond 2
San Mateo 2
Shanghai 2
Warsaw 2
Athens 1
Clifton 1
Crick 1
Fano 1
Ferrara 1
Fremont 1
Guiyang 1
Harbin 1
Helsinki 1
Henderson 1
Los Angeles 1
Monfalcone 1
Orbassano 1
Ottawa 1
Prague 1
Quzhou 1
Redwood City 1
Sacramento 1
Simi Valley 1
Sofia 1
Taizhou 1
Terenzano 1
Vienna 1
Winnipeg 1
Xian 1
Yinchuan 1
Zhengzhou 1
Totale 3.218
Nome #
Allergic responses and aryl hydrocarbon receptor novel pathway of mast cell activation. 168
APE/Ref-1 makes fine-tuning of CD40-induced B cell proliferation. 160
A novel method to generate and culture human mast cells: Peripheral CD34+ stem cell-derived mast cells (PSCMCs). 159
Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit W-sh/W-sh mice. 152
Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironment. 148
Mast cell: an emerging partner in immune interaction. 145
Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma. 145
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. 144
Functional expression of aryl hydrocarbon receptor on mast cells populating human endometriotic tissues 142
Exploring a regulatory role for mast cells: 'MCregs'? 141
Mast cells contribute to autoimmune diabetes by releasing interleukin-6 and failing to acquire a tolerogenic IL-10+ phenotype 141
Modulation of FceRI-dependent mast cell response by OX40L via Fyn, PI3K, and RhoA. 139
The aryl hydrocarbon receptor modulates acute and late mast cell responses. 139
Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation 133
The inner side of T cell lipid rafts. 129
Single-cell dynamics of mast cell-CD4+ CD25+ regulatory T cell interactions. 128
Systemic T cells immunosuppression of glioma stem cell-derived exosomes is mediated by monocytic myeloid-derived suppressor cells 125
CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. 122
Stem Cell Senescence as the Memory of Past Injuries 119
Expression and modulation of S100A4 protein by human mast cells 110
Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells 105
Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells. 102
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. 96
Earthworm leukocytes that are not phagocytic and cross-react with several human epitopes can kill human tumor cell lines. 95
Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter. 93
Mast cell within the microenvironment: Cellular and matrix cross-talk in physiopathological conditions 91
Immunomodulatory functions and molecular regulation of IL-12. 86
Involvement of a p53-dependent pathway in rubella virus-induced apoptosis. 82
Interleukin-12: an immunoregulatory cytokine produced by B cells and antigen-presenting cells. 76
The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. 75
Technical advance: Soluble OX40 molecule mimics regulatory T cell modulatory activity on FCεRI-dependent mast cell degranulation 72
The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. 53
Differentiation of human NK cells into NK1 and NK2 subsets. 46
Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15. 44
A novel ets-2-related nuclear factor is involved in transcriptional activation of the human interleukin-12 p40 gene promoter in response to interferon-gamma and LPS stimulation of monocytic cells. 37
Different requirements for alpha-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases. 36
Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. 31
Synergistic regulation of the human interleukin-12 p40 promoter by NFkappaB and Ets transcription factors in Epstein-Barr virus-transformed B cells and macrophages. 29
Positive and negative regulation of interleukin-12 gene expression. 27
T cell costimulation by chemokine receptors. 2
Totale 4.067
Categoria #
all - tutte 11.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.543


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.258 0 81 69 212 98 177 159 146 115 114 19 68
2020/2021643 14 86 24 80 37 69 30 63 69 39 99 33
2021/2022388 20 37 6 11 12 14 25 16 6 55 141 45
2022/2023381 40 45 10 44 42 101 6 21 49 2 9 12
2023/2024138 16 15 4 0 14 50 2 1 13 2 6 15
2024/202523 16 7 0 0 0 0 0 0 0 0 0 0
Totale 4.067